dabigatran has been researched along with Cancer of Gastrointestinal Tract in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grove, EL; Larsen, TB; Lip, GYH; Nielsen, PB; Ording, AG; Skjøth, F; Søgaard, M | 1 |
| Akitsu, K; Fujino, T; Ikeda, T; Koike, H; Koike, M; Shinohara, M; Suzuki, T; Yao, S; Yuzawa, H | 1 |
| Brueckmann, M; Clemens, A; Konstantinides, S; Lip, GY; Noack, H; Strack, A | 1 |
| Aisenberg, J; Brueckmann, M; Chatterjee, P; Connolly, S; Desai, J; Ezekowitz, M; Flack, KF; Ilgenfritz, J; Kolb, JM; Reilly, P; Wallentin, LC; Yusuf, S | 1 |
| Al-Kahlili, F; Gilstring, Å; Haeggström, A; Risberg, D; Tullberg, U; Wallén, H | 1 |
1 trial(s) available for dabigatran and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chemoprevention; Dabigatran; Embolism; Female; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Male; Prevalence; Prospective Studies; Stroke; Warfarin | 2017 |
4 other study(ies) available for dabigatran and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Confidence Intervals; Dabigatran; Denmark; Factor Xa Inhibitors; Female; Gastrointestinal Neoplasms; Hemorrhage; Humans; Male; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2021 |
Bleeding with oral anticoagulant dabigatran is highly associated with occult cancers in atrial fibrillation patients.
Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Incidence; Japan; Male; Middle Aged; Neoplasms, Unknown Primary; Prevalence; Retrospective Studies; Risk Factors; Stroke; Survival Rate | 2018 |
Anticoagulant-related gastrointestinal bleeding--could this facilitate early detection of benign or malignant gastrointestinal lesions?
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Early Detection of Cancer; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Incidence; Morpholines; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thiophenes; Warfarin | 2014 |
[Gastrointestinal bleeding during treatment with nonvitamin K antagonist oral anticoagulants (NOACs) may be caused by malignant lesions].
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Colonoscopy; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Male; Pilot Projects; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Vitamin K | 2016 |